HOUSTON - KBR Inc . (NYSE: NYSE:KBR), a global technology and engineering firm, has been named one of the 11 recipients of a new military health support contract. The Defense Health Agency has selected KBR for the Medical Q Coded Support and Services Next Generation (MQS2-NG) contract, which has a maximum value of $43 billion.
The contract provides KBR with the opportunity to compete for various task orders to deliver health and wellness services to U.S. military personnel and their families. Services under the MQS2-NG contract include dental, physician, and nurse medical support in Department of Defense Military Treatment Facilities (MTFs) across the United States and in strategic international locations.
KBR's role would encompass managing and staffing these facilities to assist in the treatment and recovery of service members and their families, enhancing their overall resilience and well-being. The contract spans a performance period of 10 years, with options extending from 2024 through 2034.
Byron Bright, President of KBR's Government Solutions U.S., expressed enthusiasm about the company's opportunity to augment its health and human performance services and the anticipated positive impact on the quality of care for service members and their families.
The MQS2-NG contract aligns with KBR's longstanding commitment to supporting military personnel, as evidenced by its five decades of providing vital health services. The company has previously supported hundreds of astronauts through NASA's Human Health and Performance Contract (HHPC) and the U.S. Special Operations Forces under the military's Preservation of the Force and Family (POTFF) contract.
KBR, employing approximately 35,000 people worldwide, offers science, technology, and engineering solutions to government and commercial clients in over 80 countries.
This announcement is based on a press release statement from KBR, Inc. The company's forward-looking statements, including potential future contractual performance, are subject to various risks, uncertainties, and assumptions that could affect actual outcomes. KBR advises caution in relying on these projections and commits to public updates as required by law.
InvestingPro Insights
KBR Inc. (NYSE: KBR), with its recent selection for the MQS2-NG contract, stands to strengthen its position as a key player in the health and wellness services sector for military personnel. The financial health and market sentiment surrounding KBR provide additional context for investors interested in the company's prospects.
According to InvestingPro data, KBR has a market capitalization of approximately $8.87 billion, reflecting its substantial presence in the industry. Despite a negative P/E ratio over the last twelve months as of Q1 2024, analysts are optimistic about KBR's future, predicting profitability this year. This is further evidenced by the company's PEG ratio of 0.19, suggesting that its earnings growth potential is recognized by the market.
Revenue growth remains robust with a 7.9% increase over the last twelve months as of Q1 2024, and a quarterly growth rate of 6.75% in Q1 2024. This financial momentum is consistent with KBR's historical performance, with the stock experiencing a large price uptick of 26.88% over the last six months.
InvestingPro Tips for KBR highlight that the company has raised its dividend for 4 consecutive years and maintained dividend payments for 17 consecutive years. This track record, coupled with a dividend yield of 0.91%, could be of interest to income-focused investors. Additionally, the company operates with a moderate level of debt, which may provide some reassurance regarding its financial stability.
For investors looking to delve deeper into KBR's financials and market performance, there are 11 additional InvestingPro Tips available at InvestingPro. These tips offer insights into various aspects of the company's operations and financial health. Subscribers can use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, gaining access to a wealth of investment analysis tools and data.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.